Cipla Ltd (CIPL.NS)
379.50INR
3:55pm IST
Rs-0.15 (-0.04%)
Rs379.65
Rs379.00
Rs382.00
Rs376.05
997,883
1,372,479
Rs435.00
Rs305.00
CIPL.NS
About
Overall
| Beta: | 0.41 |
| Market Cap (Mil.): | Rs304,829.09 |
| Shares Outstanding (Mil.): | 802.92 |
| Dividend: | 2.00 |
| Yield (%): | 0.53 |
Financials
| CIPL.NS | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 30.80 | 30.37 | 30.65 |
| EPS (TTM): | 12.32 | -- | -- |
| ROI: | 14.28 | 19.50 | 18.83 |
| ROE: | 15.74 | 20.27 | 19.74 |
Sweden's Meda sale talks founder on valuation: source
STOCKHOLM/MUMBAI - Swedish drugmaker Meda said it was not discussing being taken over, after a source with knowledge of the matter said talks about a deal with India's Sun Pharmaceutical Industries had foundered on valuation.
UPDATE 3-Sweden's Meda sale talks founder on valuation - source
* Generic drugs sector busy with deals (Adds Meda announcement on Cipla)
BRIEF-Drug firm Meda expands collaboration with the Indian pharma Cipla
STOCKHOLM, June 5 - Meda : * Expands collaboration with the Indian pharmaceutical company Cipla * Says the extended partnership, Meda now have full coverage in all growth
MARKET EYE-Indian shares fall; ICICI Bank, Cipla hit
* India's main BSE index falls 0.1 percent and the broader NSE index is down 0.13 percent, heading for a second day of falls ahead of the expiry of May derivatives contracts later in the day. * Asian shares and the dollar were pressured on Thursday, undermined by an overnight pullback in global equities as investors assessed the implications of a potential softening of the Federal Reserve's massive monetary stimulus programme. * ICICI Bank Ltd declines 3.3 percent, while other lenders also f
Cipla Q4 net drops 8.2 percent, lags estimates
MUMBAI - Drugmaker Cipla Ltd reported an 8.2 percent drop in quarterly net profit, lagging street estimates, as sales growth in its key domestic market slowed down.
MARKET EYE-Indian shares fall; Reliance, Cipla decline
* India's main BSE index falls 0.36 percent and the broader NSE index is down 0.4 percent, after three consecutive sessions of gains. * Asian shares also eased as strong economic data rallied U.S. stocks to record highs, throwing market focus back on to the possibility of reduced Federal Reserve monetary stimulus in the future. * Reliance Industries Ltd falls 0.4 percent on profit booking after rising 7.3 percent in the previous two sessions. * Cipla Ltd falls 0.5 percent, heading for a sixth c
MARKET EYE-India's Cipla operating profit may lag estimates-StarMine
* India's Cipla Ltd may miss January-March operating profit consensus forecasts when it reports results on Wednesday, according to Thomson Reuters StarMine data. * StarMine's SmartEstimates, which places greater emphasis on forecasts by top-rated analysts, expects Cipla to report an operating profit of 4.81 billion rupees ($86.50 million)for the quarter compared with a wider consensus mean estimate of 4.91 billion rupees. * Shares in Cipla are down 1.7 percent at 0830 GMT. (abhishek.v
Cipla Medpro shareholders back buyout by India's Cipla
JOHANNESBURG - Shareholders of South Africa's Cipla Medpro overwhelmingly approved a $488 million takeover offer from India's Cipla Ltd on Wednesday, giving the Indian drugmaker a big presence in Africa's biggest economy.
Cipla Medpro shareholders back buyout by India's Cipla
JOHANNESBURG - Shareholders of South Africa's Cipla Medpro overwhelmingly approved a $488 million takeover offer from India's Cipla Ltd on Wednesday, giving the Indian drugmaker a big presence in Africa's biggest economy.
Cipla Medpro shareholders approve buyout by India's Cipla
JOHANNESBURG, May 15 - Cipla Medpro South Africa said on Wednesday its shareholders had approved a $500 million buyout offer from India's Cipla Ltd.
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
